All companies › EMBC

EMBC · Embecta Corp.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
0
Open-market sells
1
INSIDER SCANNER signals
—
Last filing

INSIDER SCANNER signals for EMBC

Research signals this company has produced, with the reasoning recorded at the time.

A · HIGH conviction · SWING · 2026-08-12
5.15Entry reference
5.67Model target
30.0Max hold (days)
20.0%Model allocation
Hombach Robert J. · Dir, Pres, CEO, Pres, Pharm Svc, Prod Mgmt, CL, SVP, CFO

Cluster of 4 unique insiders including CEO and CFO put in ~$558K around $4.97, with one stake up 70% — genuine C-suite conviction after a strong Q3 rebound (sales $271.7M, return to profit) and raised margin/EPS guidance. Setup is the problem: RSI 80.6 and up ~60% in 20 days means insiders bought into an already-extended bounce off the earnings pop, so I'm sizing this as a swing not a runner. Net flow clean, sector beating SPY +10.7%, but heavy debt ($1.5B vs $215M cash) and an active securities class action keep it out of A+ territory.

Watch: RSI 80.6 overbought entry; up 60% in 20 days chasing risk; securities class-action lawsuit (Aug 17 lead-plaintiff deadline); high debt load; single source.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.